Total number of publications: 774
2007
-
Acyklovir v dávce 400mg denně je dostatečný pro profylaxi herpetické infekce při léčbě Velcade
XXI. Olomoucké hematologické dny s mezinárodní účastí, year: 2007
-
AMINO ACID SEQUENCES OF T CELL RECEPTOR REACTING AGAINST MULTIPLE MYELOMA
Blood reviews, year: 2007
-
ASSOCIATION BETWEEN CHROMOSOMAL CHANGES AND STANDARD PROGNOSTIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
Hematologica/The Hematology Journal, year: 2007
-
Clinical implications of 13q14 and 17p13 deletion, t(4;14) and 1q21 amplification in patients with relapsed multiple myeloma treated by Thalidomide or Bortezomib (Velcade)
Chromosome Research, year: 2007
-
Clinical implications of chromosomal aberrations (13q14 and 17p13 deletion, translocation t(4;14) and 1q21 amplification) in patients with relapsed multiple myeloma treated by thalidomide or bortezomib (Velcade)
From cell sorting to plasma cell identification and chromosomal aberrations in multiple myeloma – Application manual, year: 2007
-
Comparison of Dendritic Cells in Healthy Volunteers and Subjects with Monoclonal Gammopathy and/or Multiple Myeloma
Year: 2007, type: Conference abstract
-
Comparison of prognostic impact of chromosome 1q21 gain in patients with multiple myeloma treated by Velcade, thalidomide and any conventional therapy
Hematologica/The Hematology Journal, year: 2007
-
CORRELATION BETWEEN CHROMOSOMAL ABERRATIONS AND STANDARD PROGNOSTIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION
Blood reviews, year: 2007
-
Could Velcade show the benefit over the autologous retransplantation in relapsing multiple myeloma?
Haematologica 2007, year: 2007
-
Dendritic cell counts and their subsets during treatment of multiple myeloma
Neoplasma, year: 2007, volume: roč. 54, edition: 4